March 30, 2011 -- Shenzhen Kang Sheng Bao Bio-Technology has signed an agreement with SuperNova Diagnostics®, a Washington DC development stage company, giving KSB the responsibility to develop, manufacture and market diagnostic products that measure neopterin. Neopterin is a biomarker of immune system activity. KSB will use SuperNova’s AmpCrystal® platform. Two weeks ago, KSB and SuperNova announced KSB had licensed China rights for SuperNova’s platform. More details....
